Related Experiment Video

Updated: Jun 23, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

Parkin-induced mitophagy in the pathogenesis of Parkinson disease

Derek Narendra1, Atsushi Tanaka, Der-Fen Suen

  • 1Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Autophagy
|April 21, 2009
PubMed

Insights

Parkin knockout causes mitochondrial dysfunction. Parkin protein targets damaged mitochondria for removal via mitophagy, a process crucial for preventing Parkinson disease pathogenesis.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Genetics

Background:

  • Parkinson disease is linked to the Park2 gene, which encodes the ubiquitin ligase Parkin.
  • Parkin is typically found in the cytosol but is involved in mitochondrial quality control.

Purpose of the Study:

  • To investigate the role of Parkin in mitochondrial integrity and function.
  • To determine the mechanism of Parkin recruitment to mitochondria.

Main Methods:

  • Studied knockout Drosophila melanogaster models lacking functional Parkin.
  • Analyzed Parkin's localization and recruitment to mitochondria.
  • Assessed mitochondrial membrane potential, ATP levels, and pH.

Main Results:

  • Parkin knockout leads to impaired mitochondrial integrity and function.
  • Parkin is selectively recruited to mitochondria with reduced membrane potential.
  • Parkin recruitment is dependent on mitochondrial voltage but not ATP or pH levels.

Conclusions:

  • Parkin protein facilitates mitophagy of dysfunctional mitochondria.
  • Loss of mitochondrial membrane potential triggers Parkin-mediated mitophagy.
  • Targeted elimination of mitochondria by Parkin is implicated in Parkinson disease pathogenesis.

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.